share_log

Intra-cellular Therapies Reiterates Full Year 2024 Caplyta Net Product Sales Guidance Of $645M-$675M

Benzinga ·  May 7 19:33
Intra-cellular Therapies Reiterates Full Year 2024 Caplyta Net Product Sales Guidance Of $645M-$675M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment